Blood Loss, Surgical

Inclusion Criteria

- Men or women 18 years of age and older
 - Subjects requiring protocol specified oncological surgery. Subjects must have histological confirmation of malignancy in lung or esophagus
 - Documented, signed and dated informed consent obtained prior to any study specific procedures being performed

Exclusion Criteria

- Subjects with previous exposure to aprotinin in the last 6 months or with a known or suspected allergy to aprotinin
 - Subjects undergoing laparoscopic surgery
 - Subjects with sepsis or mesothelioma
 - Subjects with impaired renal function (serum creatinine >2.5 mg/dL or 221 micromoles/liter)
 - Subjects with a history of bleeding diathesis, deep vein thrombosis or pulmonary embolism or known coagulation factor deficiency. Based on the investigator's opinion of any active significant medical illness the subject may have. 
 - Subjects who refuse to receive allogenic blood products or whose preoperative red blood cell volume is so low that a blood transfusion would be likely to be given perioperatively (preoperative hematocrit of <24% or hemoglobin of <8 g/dl)
 - Subjects who have participated in an investigational drug study within the past 30 days
 - Subjects who are pregnant or breastfeeding or women of childbearing potential in whom the possibility of pregnancy cannot be excluded by a negative pregnancy test and who are not using a reliable method of contraception
 - Planned use of other antifibrinolytic agents, e.g.  aminocaproic acid or tranexamic acid
 - Subjects on chronic anticoagulant treatment with warfarin that cannot be temporarily discontinued for the surgical procedure (as per local practices)